Poliovirus Receptor antibody (AA 35-50, AA 60-80)

Catalog No. ABIN219957

This anti-Poliovirus Receptor antibody is a Mouse Monoclonal antibody detecting Poliovirus Receptor in FACS and IF. Suitable for Human and Monkey.

Quick Overview for Poliovirus Receptor antibody (AA 35-50, AA 60-80) (ABIN219957)

Target: Poliovirus Receptor (PVR)

Reactivity: Human, Monkey

Host: Mouse

Clonality: Monoclonal

Conjugate: This Poliovirus Receptor antibody is un-conjugated

Application: Flow Cytometry (FACS), Immunofluorescence (IF)

Product Details anti-Poliovirus Receptor Antibody

Binding Specificity: AA 35-50, AA 60-80

Specificity: Recognizes human CD155/ PVR. Species cross-reactivity: monkey. Does not react with porcine, canine, rabbit, rat, hamster and mouse.

Purification: Protein G purified

Immunogen: HeLa cells. Epitope: aa35-50. Cellular Localization: Cell membrane. MW of Antigen: 60-80kD.

Type of Immunogen: Cells

Isotype: IgG1

Application Details

Application Notes: Approved: Flo, IF

Usage: Suitable for use in Flow Cytometry and Immunofluorescence

Comment:

Target Species of Antibody: Human

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: 10 mM PBS,  pH 7.4, 0.2 % BSA, 0.09 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Avoid freeze-thaw cycles.

Storage: 4 °C,-20 °C

Storage Comment: Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.

Target Details for Poliovirus Receptor

Target: Poliovirus Receptor (PVR)

Alternative Name: PVR / CD155

Background: Name/Gene ID: PVR

Synonyms: PVR, CD155, Hpvr, HVED, Nectin-like 5, Nectin-like protein 5, Poliovirus receptors beta, Poliovirus receptor, PVS, Necl-5, CD155 antigen, NECL5, TAGE4

Gene ID: 5817

UniProt: P15151

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Cancer Immune Checkpoints, SARS-CoV-2 Protein Interactome